UK Leader in CBD Transdermal Patches - EU-GMP Facility, Diverse Product Line, Exclusive Agreements, Seeking Divestiture

UK Leader in CBD Transdermal Patches - EU-GMP Facility, Diverse Product Line, Exclusive Agreements, Seeking Divestiture
Buy / Sell / Invest:
Outright Divestiture
Location:
United Kingdom
Sq. Footage:
14,500.0 ft²

Unique, differentiated, revenue driven medical cannabis company specializing in drug-in-adhesive CBD patches and 3D printed pills, offering a significant technology transfer opportunity

  • Branded leading supplier of specialized, niche drug-in-adhesive CBD (and future THC) patches in the UK
  • Aims to manufacture and build a range of transdermal patches for the over-the-counter CBD and medical cannabis markets
  • Currently has a fully built, 14,500 ft.² EU-GMP compliant manufacturing facility, fitted as a bespoke laboratory with various sized “clean room” labs
  • Undertaking labelling, packaging, retail sales, storage and distribution of excellent product mix of CBD Patches, CBD oils, CBD Capsules, CBD Vapes & CBD Cosmetics with future plans to add HC products
  • Products are sold successfully through the company’s website and through 3rdparty platforms
  • Strong focus on SEO marketing, brand exposure, customer engagement and subscribers, which has seen customer base grown by >250%
  • Exclusive worldwide agreement in place with a specialized technology company for the manufacture of unique cannabinoid patches for the medical and over-the-counter markets
  • Exclusive partnership with 3D printer manufacturer for pills which are then sold to clinics, pharmaceutical wholesalers or sold as CBD products in the OTC market (and future THC market potential)
  • Experienced leadership team with deep operating experience, marketing, R&D and a proven track record
  • In the process of applying for Manufacturing Specials License, WDA, Controlled Drug Storage and Human Tissue license
  • Developing proprietary IP for cannabinoid patch formulations and production
  • Strategically aligned roadmap, poised for rapid growth through R&D of THC patches and 3D printed pills through key partnerships with API providers
  • Facility comes with £250,000 of fixed assets
  • Acquisition includes a successful, interactive, revenue generating magazine focused on fibromyalgia which provides pain management solutions for patients
  • Seeking outright divestiture of the brand, going-concern business, transferable technology, optional leased facility, and fixed assets
  • There is an option to purchase the real estate

Licence(s) Held:

  • Novel Food Authorisation for Capsules & Oils

 

Seeking outright divestiture of the brand, going-concern business, transferable technology, optional leased facility, and fixed assets for £1 million

View Listing

Sign In

Register

Reset Password

Please enter your username or email address, you will receive a link to create a new password via email.